Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2)

Transplantation
G A LevyA Johnston

Abstract

A prospective, open-label, study was conducted at 29 centers in 9 countries, involving 307 de novo liver transplant patients to compare the clinical usefulness of monitoring 2-hr post-dose cyclosporine (CsA) levels (C2) with conventional trough cyclosporine blood levels (pre-dose) (C0). Neoral oral therapy was initiated at 15 mg/kg/day and dose adjusted according to predetermined C2 or C0 target level ranges. The primary efficacy variable was treatment failure at 3 months, where evaluation was based on a composite endpoint of biopsy-proven rejection, treatment for rejection, graft loss, death, or premature withdrawal/discontinuation from the study. Baseline characteristics were similar between groups. Graft loss at 12 weeks (retransplantation or death) occurred in 6.8% C2 and in 7.0% C0 patients. Overall incidence of treated acute rejection was lower for C2 (23.6%) than C0 patients (31.6%) (P=0.144, Cochran-Mantel-Haenszel [CMH] test). In hepatitis C virus (HCV)-negative patients, the incidence of rejection in the C2 group was significantly less than in the C0 group (21.2% vs. 33.0%; P<0.05), whereas in HCV-positive patients, the rejection rate was similar in both groups (26.7% for C2 group vs. 27.3% for C0 group: P=0.81). C2 p...Continue Reading

References

Mar 1, 1986·Clinical Pharmacokinetics·R J PtachcinskiG J Burckart
Dec 1, 1995·Therapeutic Drug Monitoring·D W Holt, A Johnston
Sep 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R H WiesnerK M Detre
Jul 1, 1999·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·D G OrmondeW D Reed

❮ Previous
Next ❯

Citations

Sep 1, 2004·Transplant International : Official Journal of the European Society for Organ Transplantation·D A HesselinkT van Gelder
Sep 7, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Diego H DelgadoHeather J Ross
Mar 26, 2004·Transplantation Proceedings·T Casanovas Taltavull
Mar 26, 2004·Transplantation Proceedings·L FritscheK Budde
Mar 26, 2004·Transplantation Proceedings·S G Pollard
Mar 26, 2004·Transplantation Proceedings·L PapeG Offner
Mar 26, 2004·Transplantation Proceedings·M CantarovichJ Tchervenkov
Mar 26, 2004·Transplantation Proceedings·D H Delgado, H J Ross
Mar 26, 2004·Transplantation Proceedings·A JorgaA Johnston
Mar 26, 2004·Transplantation Proceedings·M Billing-Grima, P Wolf
Mar 26, 2004·Transplantation Proceedings·G A Levy
Mar 26, 2004·Transplantation Proceedings·A BusauschinaF J van der Woude
Mar 26, 2004·Transplantation Proceedings·H Furukawa, S Todo
Mar 26, 2004·Transplantation Proceedings·K Midtvedt
Mar 26, 2004·Transplantation Proceedings·S BeckebaumC E Broelsch
Mar 26, 2004·Transplantation Proceedings·F VincentiS Feng
Mar 26, 2004·Transplantation Proceedings·F Citterio
Sep 2, 2003·Transplantation Proceedings·A SantanaM Martins Prata
Jul 16, 2003·Clinical Therapeutics·Stephen PollardUNKNOWN CONSENT: Consensus on Substitution in European Transplantation
Sep 13, 2002·Clinical Transplantation·Mark D PescovitzUNKNOWN Simulect US01 Study Group
Sep 19, 2006·Bone Marrow Transplantation·M P HendriksJ P Donnelly
May 23, 2002·Transplantation·Björn NashanEric Thervet
May 23, 2002·Transplantation·Gary LevyUNKNOWN Consensus on Neoral C(2): Expert Review in Transplantation (CONCERT) Group
Nov 23, 2006·Inflammatory Bowel Diseases·Audrey WeberFranck Carbonnel
Jul 17, 2004·Transplantation·Laurence Bonhomme-FaivreVéronique Picard
Jun 9, 2005·Transplantation·Helen M EvansDeirdre A Kelly
Jun 26, 2007·Transplantation·Simon R Knight, Peter J Morris
Apr 15, 2008·Transplantation·Marcelo CantarovichUNKNOWN Motown Study Group
Dec 23, 2004·Transplant International : Official Journal of the European Society for Organ Transplantation·Alida L P CaforioGino Gerosa
Feb 24, 2007·Nephrology·Paul Trevillian, UNKNOWN Caring for Australians with Renal Impairment (CARI)
Apr 15, 2004·Gut·J Neuberger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.